Skip to content

A Comparative Study on the Anti-inflammatory Effects of Tranexamic Acid and Non-steroidal Anti-inflammatory Drugs in Elderly Patients Undergoing Knee Arthroscopy Surgery

A Comparative Study on the Anti-inflammatory Effects of Tranexamic Acid and Non-steroidal Anti-inflammatory Drugs in Elderly Patients Undergoing Knee Arthroscopy Surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122494
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative inflammatory response

Interventions

TXA Group:Intravenous infusion of tranexamic acid 1.5g 30 min before surgery (diluted to 100 ml normal saline 0.9%, completed within 15 min)
no NSAIDs allowed during perioperative period and study observation period
KET Group:Intravenous infusion of ketorolac tromethamine 30 mg 30 min before surgery (diluted to 100 ml normal saline 0.9%, completed within 15 min)
no tranexamic acid or similar agents allowed during perioperative period and study observation period

Sponsors

The First Hospital Of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Elderly patients aged >=65 years, regardless of gender, with ASA grades I to III who are scheduled for unilateral knee arthroscopic surgery under general anesthesia

Exclusion criteria

Exclusion criteria: 1.People allergic to tranexamic acid or NSAIDs; 2.Those with concurrent cardiovascular or cerebrovascular diseases; 3.Those with abnormal blood coagulation function; 4.Those with severely abnormal liver and kidney functions; 5.Those with a history of deep vein thrombosis or pulmonary embolism; 6.People who have been using hormone drugs or NSAIDs for a long time; 7.Patients who are unable to cooperate to complete the assessment; 8.Those who have recently undergone heavy manual surgery; 9.Refuse to participate in this researcher;

Design outcomes

Primary

MeasureTime frame
The serum IL-6 level of postoperative patients;Postoperative serum C-reactive protein level;

Secondary

MeasureTime frame
Pain score;He occurrence of adverse reactions;Postoperative venous blood biochemical indicators;

Countries

China

Contacts

Public ContactDeng Kang

The First Hospital Of Jiaxing

jxmzdk@126.com+86 13736446844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026